For decades though there has been an efficient saga of extensive rseearches in the subjct of stem cell producing proficient results, on the contrary a strange confusion has always persisted among the scientists over the enactment of the concerned legisation. In the recent days in this esteem it has been perceived that the renowned stem cell scientists throughout the length and breadth of Europe are trying in all measures to influence the European government for the modification of the embryonic stem cell legislation in the entire continent.   In this direction the well-known scientists from two European-funded groups like the EuroStemCell (European Consortium for Stem Cell Research) and ESTOOLS are working in accord for the manifestation of the very impact of the naional legislation on the field international research in European countries, for instance Germany and Italy.   

According to them there is the need of a relaxation of the present laws since they are fastening the necessary applications. It is due to this crude reality the scientists of these organizations, pioneer in this very field are making a call to their European counterparts and anticipate that the later shall be able to cofunction on international projects without fear of legal reprisal. It is to be noted at the same time thata there is the existence of a great differentiation in the process of legislation of the stem cell throughout the European continent. For the benediction of the readers, the application of the legalised projects in countries such as Sweden and the UK could result in a three-year prison sentence in Germany. What's more, the researchers from countries with very restrictive legislation might also become responsible by taking on coordinating positions in other European institutions.

Speaking on the occasion Professor Peter Andrews, of the University of Sheffield's Centre for Stem Cell Biology and coordinator of the ESTOOLS consortium, said: "Despite common funding through the 6th and 7th framework of the European Commission, current legislation means that scientists within Europe cannot freely exchange personnel and cell lines." "This has huge consequences for stem cell research in Europe, limiting the ability of researchers with different expertise in different countries to work together for the common good," he added.